Association between polymorphisms of EPHX1 and XRCC1 genes and the risk of childhood acute lymphoblastic leukemia

Archives of Toxicology

Volumn 86, Issue 3, 2012, Pages 431-439

  Tumer, Tugba Boyunegmez ^a,b   Sahin, Gurses ^c   Arinç, Emel ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

^c DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

Author keywords

Childhood ALL; EPHX1; Genetic polymorphism; Risk assessment; XRCC1

Indexed keywords

ARGININE; GLUTAMINE; HISTIDINE; TYROSINE; XRCC1 PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; EPHX1 GENE; EXON; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTANT; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; TURKEY (REPUBLIC); WILD TYPE; XRCC1 GENE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; EPOXIDE HYDROLASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS;

EID: 84858069352     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-011-0760-8     Document Type: Article

References (55)

1. Alves S, Amorim A, Ferreira F, Norton L, Prata MJ (2002) The GSTM1 and GSTT1 genetic polymorphisms and susceptibility to acute lymphoblastic leukemia in children from north Portugal. Leukemia 16(8):1565-1567
2. Arand M, Herrero Plana ME, Hengstler JG, Lohmann M, Cronin A, Oesch F (2003) Detoxification strategy of epoxide hydrolase-the basis for a threshold in chemical carcinogenesis. EXCLI J 2:22-30
3. Arinç E (2010) The role of polymorphic cytochrome P450 enzymes in drug design, development and drug interactions with a special emphasis on phenotyping. J Mol Catal B Enzyme 64:120-122
4. Arinç E, Philpot RM (1976) Preparation and properties of partially purified pulmonary cytochrome P-450 from rabbits. J Biol Chem 251:3213-3220
5. Arinç E, Sen A (1994) Effects of in vivo benzo(a)pyrene treatment on liver microsomal mixed-function oxidase activities of gilthead seabream (Sparus aurata). Comp Biochem Physiol Pharmacol Toxicol Endocrinol 107(3):405-414 (Pubitemid 24107089)
6. Arinç E, Adali O, İşcan M, Güray T (1991) Stimulatory effects of benzene on rabbit liver and kidney microsomal cytochrome P-450 drug metabolizing enzymes. Arch Toxicol 65:186-190
7. Arinç E, Adali O, Gencler-Ozkan AM (2000a) Induction of N-nitrosodimethylamine metabolism in liver and lung by in vivo pyridine treatments of rabbits. Arch Toxicol 74:329-334 (Pubitemid 30660936)
8. Arinç E, Adali O, Gençler-Özkan AM (2000b) Stimulation of aniline, p-nitrophenol and N-nitrosodimethylamine metabolism in kidney by pyridine treatments of rabbits. Arch Toxicol 74:527-532
9. Arinç E, Arslan S, Adali O (2005) Differential effects of diabetes on CYP2E1 and CYP2B4 proteins and associated drug metabolizing enzyme activities in rabbit liver. Arch Toxicol 79:427-433 (Pubitemid 41191380)
10. Arinç E, Arslan S, Bozcaarmutlu A, Adali O (2007) Effects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation of carcinogenic activity of N-nitrosodimethylamine in kidney and lung. Food Chem Toxicol 45:107-118 (Pubitemid 44792320)
11. Bellucci G, Berti G, Chiappe C, Lippi A, Marioni F (1987) The metabolism of carbamazepine in humans: steric course of the enzymatic hydrolysis of the 10, 11-epoxide. J Med Chem 30:768-773 (Pubitemid 17119517)
12. Boccia S, Sayed-Tabatabaei FA, Persiani R, Gianfagna F, Rausei S, Arzani D, La Greca A, D'Ugo D, La Torre G, van Duijn CM, Ricciardi G (2007) Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population. BMC Cancer 7:206
13. Bolufer P, Collado M, Barragán E, Cervera J, Calasanz MJ, Colomer D, Roman-Gómez J, Sanz MA (2007) The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia. Haematologica 92(3):308-314 (Pubitemid 350143539)
14. Celkan T (2007) Ç ocukluk Çaǧi Akut Lenfoblastik Lösemisi. Klinik Gelişim 20(2):14-26
15. Clavel JS, Bellec S, Rebouissou F, Menegaux J, Feunteun C, Bonaiti-Pellie A, Baruchel K, Kebaili A, Lambilliotte G, Leverger D, Sommelet B, Lescoeur P (2005) Childhood leukemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy. Eur J Cancer Prev 14:531-540 (Pubitemid 41689653)
16. Decker M, Arand M, Cronin A (2009) Mammalian epoxide hydrolases in xenobiotic metabolism and signalling. Arch Toxicol 83(4):297-318
17. Erkisi Z, Yaylim-Eraltan I, Turna A, Görmüs U, Camlica H, Isbir T (2010) Polymorphisms in the microsomal epoxide hydrolase gene: role in lung cancer susceptibility and prognosis. Tumori 96:756-763
18. Falany CN, McQuiddy P, Kasper CB (1987) Structure and organization of the microsomal xenobiotic epoxide hydrolase gene. J Biol Chem 262:5924-5930
19. Friedberg T, Lollmann B, Becker R, Holler R, Oesch F (1994) The microsomal epoxide hydrolase has a single membrane signal anchor sequence which is dispensable for the catalytic activity of this protein. Biochem J 303(Pt 3):967-972 (Pubitemid 24326036)
20. Fritz P, Behrle E, Zanger UM, Mürdter T, Schwarzmann P, Kroemer HK (1996) Immunohistochemical assessment of human microsomal epoxide hydrolase in primary and secondary liver neoplasm: a quantitative approach. Xenobiotica 26(1):107-116 (Pubitemid 26108104)
21. Goode EL, White KL, Vierkant RA, Phelan CM, Cunningham JM, Schildkraut JM et al (2011) Xenobiotic-metabolizing gene polymorphisms and ovarian cancer risk. Mol Carcinog 50(5): 397-402
22. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ (1994) Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3:421-428 (Pubitemid 24083901)
23. Hengstler JG, Arand M, Herrero ME, Oesch F (1998) Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res 154:47-85
24. Hoeijmakers JHJ (2001) Genome maintenance mechanisms for preventing cancer. Nature 411:366-374
25. Jackson MA, Stack HF, Rice JM, Waters MD (2000) A review of the genetic and related effects of 1,3-butadiene in rodents and humans. Mutat Res 463:123-181
26. Jain M, Tilak AR, Upadhyay R, Kumar A, Mittal B (2008) Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer. Toxicol Appl Pharmacol 230(2):247-251
27. Johansson I, Ingelman-Sundberg M (1988) Benzene metabolism by ethanol-, acetone-, and benzene-inducible cytochrome P-450 (IIE1) in rat and rabbit liver microsomes. Cancer Res 48:5387-5390
28. Johansson I, Ingelman-Sundberg M (2011) Genetic polymorphism and toxicology - with emphasis on cytochrome P450. Toxicol Sci 120(1):1-13
29. Khedhaier A, Hassen E, Bouaouina N, Gabbouj S, Ahmed SB, Chouchane L (2008) Implication of xenobiotic metabolizing enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma. BMC Cancer 8:109
30. Kiss I, Orsós Z, Gombos K, Bogner B, Csejtei A, Tibold A, Varga Z, Pázsit E, Magda I, Zölyomi A, Ember I (2007) Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. Anticancer Res 27(4C):2931-2937 (Pubitemid 47228023)
31. Korhonen S, Romppanen EL, Hiltunen M, Helisalmi M, Punnonen K, Hippela M, Heinonen S (2003) Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are associated with polycystic ovary syndrome. Fertil Steril 79:1353-1357 (Pubitemid 36687881)
32. Krajinovic M, Labuda D, Richer C, Karimi S, Sinnett D (1999) Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 93(5):1496-1501 (Pubitemid 29102475)
33. Lahiri DK, Schnabel B (1993) DNA Isolation by a rapid method from human blood samples: effects of MgCl2, EDTA, storage time and temperature on DNA yield and quality. Biochem Genet 31(7/9):321-328 (Pubitemid 23316953)
34. Lanzkowsky P (2000) Leukemias. In: Lanzkowsky P (ed) Manual of peadiatric hematology and oncology, 3rd edn. Academic Press, San Diego, pp 359-411
35. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA (1999) XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 59(11):2557-2661
36. McKinney PA, Alexander FE, Cartwright RA, Parker L (1991) Parental occupations of children with leukemia in west Cumbria, north Humberside, and Gateshead. BMJ 302:681-687
37. Mittal RD, Srivastava DL (2007) Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer. DNA Cell Biol 26(11):791-798 (Pubitemid 350125201)
38. Nebert DW, Ingelman-Sundberg M, Daly AK (1999) Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug metabolizing enzyme genes, their functional importance, and nomenclature issues. Drug Metab Rev 31(2):467-487 (Pubitemid 29222673)
39. Oesch F (1973) Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 5:305-340
40. Recio L, Bauer A, Faiola B (2005) Use of genetically modified mouse models to assess pathways of benzene-induced bone marrow cytotoxicity and genotoxicity. Chem Biol Interact 153-154: 159-164 (Pubitemid 40797806)
41. Ribera JM, Oriol A (2009) Acute lymphoblastic leukemia in adolescents and young adults. Hematol Oncol Clin North Am 23(5):1033-1042
42. Ross JA, Davies SM, Potter JD, Robison LL (1994) Epidemiology of childhood leukemia with a focus on infants. Epidemiol Rev 16:243-272
43. Silveira Vda S, Canalle R, Scrideli CA, Queiroz RG, Tone LG (2009) Role of the CYP2D6, EPHX1, MPO, and NQO1 genes in the susceptibility to acute lymphoblastic leukemia in Brazilian children. Environ Mol Mutagen 51(1):48-56
44. Sirma S, Agaoglu L, Yildiz I, Cayli D, Horgusluoglu E, Anak S, Yuksel L, Unuvar A, Celkan T, Apak H, Karakas Z, Devecioglu O, Ozbek U (2004) NAD(P)H: quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia. Pediatr Blood Cancer 43(5):568-570 (Pubitemid 39313956)
45. Smith CAD, Harrison DJ (1997) Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350:630-633 (Pubitemid 27367797)
46. Srivastava DS, Mandhani A, Mittal RD (2008) Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India. Arch Toxicol 82(9):633-639
47. Tilak AR, Kumar S, Jain M, Pant MC, Das BC, Guleria R et al (2011) Association of functionally important polymorphism of microsomal epoxide hydrolase gene (EPHX1) with lung cancer susceptibility. Cancer Invest 29(6):411-418
48. Tumer TB, Ulusoy G, Adali O, Sahin G, Gozdasoglu S, Arinç E (2007) The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia. Am J Hematol 82(10):906-910 (Pubitemid 47502696)
49. Tumer TB, Yilmaz D, Tanrikut C, Sahin G, Ulusoy G, Arinç E (2010) DNA repair XRCC1 Arg399Gln polymorphism alone, and in combination with CYP2E1 polymorphisms significantly contribute to the risk of development of childhood acute lymphoblastic leukemia. Leuk Res 34(10):1275-1281
50. Ulusoy G, Adali O, Tumer TB, Sahin G, Gozdasoglu S, Arinç E (2007a) Significance of genetic polymorphisms at multiple loci of CYP2E1 in the risk of development of childhood acute lymphoblastic leukemia. Oncology 72(1-2):125-131 (Pubitemid 350249140)
51. Ulusoy G, Arinç E, Adali O (2007b) Genotype and allele frequencies of polymorphic CYP2E1in the Turkish population. Arch Toxicol 10:711-718 (Pubitemid 47512602)
52. Vidal AE, Boiteux S, Hickson ID, Radicella JP (2001) XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J 20:6530-6539 (Pubitemid 33078725)
53. Whitehouse CJ, Taylor RM, Thistlethwaite A, Zhang H, Karimi-Busheri F, Lasko DD, Weinfeld M, Caldecott KW (2001) XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell 104:107-117 (Pubitemid 32144976)
54. Wickliffe JK, Ammenheuser MM, Salazar JJ, Abdel-Rahman SZ, Hastings-Smit DA, Postlethwait EM, Lloyd RS, Ward JB (2003) A model of sensitivity: 1,3-butadiene increases mutant frequencies and genomic damage in mice lacking a functional microsomal epoxide hydrolase gene. Environ Mol Mutagen 2:106-110 (Pubitemid 37087473)
55. Wickliffe JF, Herring SM, Hallberg LM, Galbert LA, Masters OE, Ammenheuser MM, Xie J, Friedberg EC, Lloyd RS, Abdel Rahman SZ, Ward JB (2007) Detoxification of olefinic epoxides and nucleotide excision repair of epoxide-mediated DNA damage: insights from animal models examining human sensitivity to 1,3-butadiene. Chem Biol Interact 20:226-231 (Pubitemid 46413209)